Here, we demonstrate that inhibition of the oncogenic kinase BCR::ABL1 in chronic myeloid leukemia (CML) cells induces ribosome collisions and activates the ribotoxic stress response (RSR). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.